RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Marcia Cruz-Correa to Stomach Neoplasms

This is a "connection" page, showing publications Marcia Cruz-Correa has written about Stomach Neoplasms.
Connection Strength

3.144
  1. Montes-Rodr?guez IM, Centeno-Girona H, P?rez-M?rtir SV, Rivera N, Cruz-Correa M. Actionable Genes and Carcinogenic Pathways for Gastric Cancer in Latinos. Cancer Med. 2025 Sep; 14(17):e71216.
    View in: PubMed
    Score: 0.797
  2. Cruz-Correa M, Xu RH, Moehler M, Oh DY, Kato K, Spigel D, Arkenau HT, Tabernero J, Zimina AV, Bai Y, Shi J, Lee KW, Hirano H, Wyrwicz L, Cid RP, Xu H, Sheng T, Barnes G. Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment of advanced gastric or gastroesophageal junction adenocarcinoma: patient-reported outcomes in the RATIONALE-305 study. Curr Med Res Opin. 2025 Jun; 41(6):1007-1016.
    View in: PubMed
    Score: 0.786
  3. Gonzalez-Pons M, Torres-Cintr?n CR, Soto-Salgado M, Vargas-Ramos Y, Perez-Portocarrero L, Morgan DR, Cruz-Correa M. Racial/ethnic disparities in gastric cancer: A 15-year population-based analysis. Cancer Med. 2023 01; 12(2):1860-1868.
    View in: PubMed
    Score: 0.640
  4. Marqu?s-Lespier JM, Gonz?lez-Pons M, Cruz-Correa M. Current Perspectives on Gastric Cancer. Gastroenterol Clin North Am. 2016 09; 45(3):413-28.
    View in: PubMed
    Score: 0.427
  5. Moehler M, Oh DY, Kato K, Arkenau T, Tabernero J, Lee KW, Rha SY, Hirano H, Spigel D, Yamaguchi K, Wyrwicz L, Disel U, Pazo-Cid RA, Fornaro L, Xu Y, Sheng T, Yang S, Kadva A, Cruz-Correa M, Xu RH. First-Line Tislelizumab Plus Chemotherapy for Advanced Gastric Cancer with Programmed Death-Ligand 1 Expression?=?1%: A Retrospective Analysis of RATIONALE-305. Adv Ther. 2025 May; 42(5):2248-2268.
    View in: PubMed
    Score: 0.193
  6. Montalvan-Sanchez EE, Hernandez-Marrero J, Norwood DA, Gonz?lez-Pons M, Dominguez RL, Rodriguez LM, Richmond E, Limburg PJ, Cruz-Correa M, Morgan DR. Establishment of a Mesoamerican-Caribbean South-South Research Platform: Challenges in the Meriva (Curcuminoids) Gastric Cancer Chemoprevention Trial. Cancer Prev Res (Phila). 2024 Dec 03; 17(12):549-555.
    View in: PubMed
    Score: 0.189
  7. Zuo QS, Yan R, Feng DX, Zhao R, Chen C, Jiang YM, Cruz-Correa M, Casson AG, Kang XD, Han F, Chen T. Loss of imprinting and abnormal expression of the insulin-like growth factor 2 gene in gastric cancer. Mol Carcinog. 2011 May; 50(5):390-6.
    View in: PubMed
    Score: 0.072
  8. Torbenson M, Lee JH, Cruz-Correa M, Ravich W, Rastgar K, Abraham SC, Wu TT. Sporadic fundic gland polyposis: a clinical, histological, and molecular analysis. Mod Pathol. 2002 Jul; 15(7):718-23.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support